格隆汇1月19日丨美丽田园医疗健康(02373.HK)公告，根据对集团截至2025年12月31日止年度(「报告期 间」)之未经审核综合管理账目之初步评估及董事会现时可得资料，集团预期录得以下财务业绩：(i)收 入不少于人民币30亿元，较2024年同期相比增长不少于16%；(ii)经调整净利润不少于人民币380百万 元，较2024年同期相比增长不少於40%；及(iii)净利润不少于人民币3.4亿元，较2024年同期相比增长不 少于34%。 ...

Group 1 - The event "New Year Sending Blessings, Welcoming the Year of the Horse" was organized by various local organizations, including the community committee and local police, to engage residents in festive activities and provide community services [1][3]. - Volunteers from Beike Real Estate (Yancheng) provided hot eight-treasure porridge and ginger tea to residents, showcasing the company's commitment to community service and care during winter [3][4]. - The event featured a public safety campaign where police distributed anti-fraud materials and educated residents on dog management regulations, enhancing community awareness of safety issues [3][4]. Group 2 - Yancheng Shuangbao Dental Hospital engaged residents with interactive activities related to oral health, including a themed lecture on dental care during the Spring Festival, thereby strengthening the hospital's brand image and community relations [4][6]. - The Yancheng Yunhe Calligraphy and Painting Institute provided free calligraphy services, creating a festive atmosphere and allowing residents to receive personalized couplets, which was well-received by the community [6]. - Local banks set up informational booths to educate residents about financial fraud prevention, particularly targeting vulnerable groups like the elderly, emphasizing the importance of awareness in financial matters [6].

Core Viewpoint - Tongce Medical (600763) shows a steady performance with a slight increase in stock price and positive financial results for the third quarter of 2025, indicating potential growth in the medical services sector [1][2]. Financial Performance - For the first three quarters of 2025, Tongce Medical reported a main revenue of 2.29 billion yuan, a year-on-year increase of 2.56% [2]. - The net profit attributable to shareholders reached 514 million yuan, up 3.16% year-on-year, while the net profit excluding non-recurring items was 509 million yuan, reflecting a 3.09% increase [2]. - In Q3 2025 alone, the company achieved a single-quarter revenue of 842 million yuan, a 2.34% increase year-on-year, and a net profit of 192 million yuan, up 2.31% year-on-year [2]. - The company's debt ratio stands at 25.1%, with investment income of 41.22 million yuan and financial expenses of 31.93 million yuan, resulting in a gross profit margin of 41.69% [2]. Market Activity - As of January 19, 2026, Tongce Medical's stock closed at 45.1 yuan, marking a 0.6% increase with a turnover rate of 3.42% and a trading volume of 153,100 hands, amounting to a total transaction value of 694 million yuan [1]. - The net inflow of main funds was 33.53 million yuan, accounting for 4.83% of the total transaction value, while retail investors experienced a net outflow of 53.02 million yuan, representing 7.64% of the total transaction value [1]. Analyst Ratings - Over the past 90 days, seven institutions have provided ratings for Tongce Medical, with four giving a "buy" rating and three an "increase" rating [2]. - The average target price set by institutions in the last 90 days is 5.288 billion yuan [2].

Group 1 - Ping An Good Doctor has accumulated extensive experience in healthcare management and established a global medical service network, with a leading in-house doctor team, and was listed on the Hong Kong Stock Exchange in 2018 [1] - The company focuses on building a comprehensive service network covering "online, in-hospital, at home, and at enterprises," creating a closed-loop healthcare service that spans all scenarios and life cycles [1] - Ping An Good Doctor leverages its self-developed "Ping An Medical Assistant" AI model and the "7+N+1" product system to enhance service quality and efficiency, serving over 10 million users with an average of over 300,000 consultations per day and a satisfaction rate exceeding 98% [1] Group 2 - Ping An Butler, under the "9073" elderly care framework, has developed a one-stop home care solution covering the entire life cycle, emphasizing three major service plans: "care when sick, assistance for safety, and protection for aging" [1] - The service model includes "1 doctor butler + N specialist teams + case management teams," providing longevity management, chronic disease management, and medical treatment services, along with innovative travel products in locations like Huangshan, Anhui, and Yidu, Hubei [1] - At the "First Beijing Trademark Brand Ceremony," Ping An Good Doctor and Ping An Butler were both selected for the "Beijing Key Trademark Protection Directory" for 2025, reflecting their strong brand reputation and solid business moat [3]

Core Viewpoint - The medical services sector experienced a decline of 1.45% on January 19, with Chengdu Xian Dao leading the drop. The Shanghai Composite Index rose by 0.29%, while the Shenzhen Component Index increased by 0.09% [1]. Group 1: Market Performance - The medical services sector saw a significant outflow of 1.45%, with Chengdu Xian Dao's stock price falling by 6.82% to 32.80 [2]. - Major stocks in the medical services sector included New Mileage, which rose by 9.83% to 2.57, and ST Biological, which increased by 5.06% to 8.93 [1][2]. - The total net outflow of main funds in the medical services sector was 1.983 billion, while retail investors saw a net inflow of 1.942 billion [2][3]. Group 2: Individual Stock Performance - New Mileage had a closing price of 2.57 with a trading volume of 3.1192 million shares, resulting in a transaction amount of 778 million [1]. - Chengdu Xian Dao, despite leading the decline, had a trading volume of 292,200 shares and a transaction amount of 976 million [2]. - The stock performance varied significantly, with some stocks like ST Biological and Huazhong Medical showing positive movements, while others like Chengdu Xian Dao and Meinian Health faced notable declines [2][3].

Core Insights - The article discusses the establishment of a brain-computer interface (BCI) outpatient clinic at Wuxi People's Hospital, aimed at treating refractory neurological and psychiatric disorders, with a focus on multidisciplinary collaboration for patient care [1][10]. Group 1: Outpatient Services - The BCI outpatient clinic offers a multidisciplinary team (MDT) approach, where specialists from various departments collaborate to diagnose and propose treatment plans for patients, as demonstrated by a case of a patient suspected of early Parkinson's disease [1][3]. - The clinic utilizes advanced diagnostic techniques, including imaging studies and expert consultations, to assess patients' conditions and recommend treatment options [3]. Group 2: Rehabilitation Facilities - A dedicated clinical research ward for BCI has been established, where patients with conditions like stroke-related paralysis can engage in rehabilitation exercises using BCI technology, which allows for passive movement through visual cues [5][10]. - The rehabilitation process involves capturing brain signals through electrodes and translating them into actions, enabling patients to perform movements or swallowing exercises with the aid of technology [5][10]. Group 3: Comprehensive Treatment Approach - The BCI system encompasses a full treatment chain, including assessment, diagnosis, treatment, and rehabilitation, integrating BCI and neuro-regulation technologies to provide a one-stop precision treatment platform for patients with conditions such as stroke, spinal cord injury, Parkinson's disease, and Alzheimer's disease [10][12]. - The hospital aims to lead in the development of BCI technologies, focusing on both invasive and non-invasive methods, and plans to establish academic organizations and regional alliances to foster collaborative innovation in the field [12]. Group 4: Future Developments - The hospital's neurology department has been conducting deep brain stimulation (DBS) surgeries since 2017 and is advancing in open-loop BCI technology, accumulating significant data and experience in neural signal collection and response regulation [12]. - The BCI technology is expected to revolutionize the fields of neuro-regulation and rehabilitation, with potential future applications in cognitive function restoration and speech communication rehabilitation [12].

人工智能的健康发展离不开高素质人才的支撑，多位委员强调了人工智能教育的重要性。德州市政协委 员、德州财富软件科技有限公司总经理高健带来《关于加快德州人工智能教育研学基地建设的建议》。 他在接受采访时表示，建议将人工智能研学基地建设，纳入德州市教育发展规划和城市总体建设规划， 整合教育资源，强化课程建设，注重科旅产教研学赛相互融合。通过打造一个"集研学、培训、竞赛、 体验科普"于一体的德州市人工智能教育研学培训基地，能够为德州高质量发展积蓄源源不断的创新动 能。 当前，人工智能正以前所未有的速度重塑各行业格局。委员们紧扣时代脉搏，从不同领域以及不同角 度，围绕人工智能各抒己见、积极建言，既立足当下实际需求，又着眼长远发展目标，助力德州经济社 会高质量发展、开启智慧德州新篇章。 委员们也将目光放到人工智能与传统产业的深度融合上。比如，德州市政协委员、山东天歌农牧发展有 限公司董事长王振武带来《关于加快推进人工智能在畜牧业中的应用，助力现代农业高质量发展的建 议》。 王振武指出，畜牧业是农业的重要组成部分，关系到国家粮食安全、农民增收和乡村振兴。随着人工智 能技术的迅猛发展，其在图像识别、大数据分析、智能决策、自动 ...

消息面上，1月15日，康龙化成发布公告，拟配售近5844.08万股新H股，配售价每股22.82港元，较1月 14日收市价折让约8.5%，募资所得款项净额约13.19亿港元，其中约70%将用于公司的项目建设，以加 强实验室服务设施、药物工艺开发及生产设施的能力及产能。 康龙化成（300759）(03759)再跌超3%，截至发稿，跌3.41%，报22.12港元，成交额1.13亿港元。 此外，康龙化成近日公布业绩预告，预计2025年归属于上市公司股东的净利润为16.14亿元-16.86亿元， 比上年同期下降6%-10%。报告期内，公司营业收入同比增长13%-16%，扣除非经常性损益后的净利润 同比增长36%-41%。 ...

Group 1 - The core point of the news is that Meinian Health experienced a decline of 5.09% in its stock price, reaching 7.27 yuan per share, with a trading volume of 2.84 billion yuan and a turnover rate of 9.87%, resulting in a total market capitalization of 28.457 billion yuan [1] - Meinian Health is primarily engaged in health check-ups and health management services, with 95.67% of its revenue coming from check-up services and 4.33% from other services [1] Group 2 - From the perspective of major fund holdings, Guotai Fund has a significant position in Meinian Health, with its Guotai Health Stock A fund reducing its holdings by 1.473 million shares in the third quarter, now holding 3.4602 million shares, which constitutes 5.36% of the fund's net value, ranking as the ninth largest holding [2] - The Guotai Health Stock A fund has a total scale of 303 million yuan, with a year-to-date return of 16.32%, ranking 124 out of 5580 in its category, and a one-year return of 21.33%, ranking 3312 out of 4226 [2] Group 3 - The fund manager of Guotai Health Stock A is Xu Zhibiao, who has been in the position for 10 years and 156 days, managing assets totaling 4.327 billion yuan, with the best fund return during his tenure being 201.92% and the worst being -21.69% [3]

Core Viewpoint - The influx of foreign patients seeking medical treatment in China raises questions about the potential impact on domestic healthcare resources, but the actual number of foreign patients is relatively small compared to the overall patient volume in cities like Shanghai [4][5]. Group 1: Foreign Patients and Healthcare Resources - In Shanghai, the total number of foreign and Hong Kong, Macau, and Taiwan inpatients in the first half of 2024 was only 4,128, which is negligible compared to the millions of outpatient and inpatient visits each year [4]. - The stories of foreign patients receiving treatment in China are often highlighted on social media, creating a perception of a larger presence than reality [5]. Group 2: Global Position of Chinese Healthcare - The phenomenon of foreign patients coming to China for medical care reflects the global positioning of the Chinese healthcare system and its potential advantages in the international market [5]. - China faces a significant annual deficit in service trade, with over one trillion RMB spent on travel services abroad, indicating a need to attract high-end consumption back to China [5]. Group 3: Advantages of Chinese Healthcare - China's healthcare system benefits from extensive clinical experience, particularly in handling complex and critical illnesses, as well as cost advantages due to a complete industrial system and controlled labor costs [6]. - The unique Chinese medicine system contributes to the reputation of "high-cost performance healthcare" among patients from developing countries and the middle class in developed nations [6]. Group 4: Challenges in Global Healthcare Market - To become a global healthcare provider, China must overcome challenges related to international recognition and trust, as well as system integration for payment and insurance processes [6]. - Cultural and service soft power aspects, such as multilingual environments and understanding of diverse cultures, are essential for building trust with international patients [6]. Group 5: Future Prospects - Initiatives like international medical tourism pilot programs and the establishment of international medical departments in public hospitals indicate progress in China's healthcare sector [7]. - The arrival of foreign patients could potentially drive improvements and upgrades within the Chinese healthcare system, fostering a transition from domestic leadership to international standards [7]. - China's role in global health governance is evolving, aiming to shift from being a supplier of medical products to a provider of health solutions and a setter of medical standards [7].